Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Share News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.40
Bid: 27.10
Ask: 27.70
Change: -0.30 (-1.08%)
Spread: 0.60 (2.214%)
Open: 27.70
High: 27.70
Low: 27.40
Prev. Close: 27.70
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

hVIVO Partnering With PrEP Biopharm, But No Revenue Until 2016

Mon, 02nd Nov 2015 09:56

LONDON (Alliance News) - Life sciences company hVIVO PLC on Monday said it has made an investment in PrEP Biopharm Ltd in order to continue the development of its PrEP-001 prophylactic compound but said any revenue from from the project will not be booked until 2016.

hVIVO is a life sciences company focused on human challenge models for pharmaceutical and biotechnology companies, which involves inducing infections in healthy volunteers to test the efficacy of vaccines or study the progression of the disease.

hVIVO said it will acquire a "significant" stake in PrEP Biopharm for GBP14.0 million, and PrEP will contract hVIVO Services Ltd to handle a GBP10.0 million phase IIa clinical programme of work on its compound in 2015 and 2016.

PrEP-001 is a nasally-administered treatment designed to prevent upper respiratory tract infections and viruses.

"We are delighted to be continuing the development of this important product, now as a key stakeholder and significant shareholder. Working closely with PrEP, we look forward to leveraging the hVIVO platform to its full potential, accelerating PrEP-001 through its clinical development in order to reach patients soonest," said hVIVO Chief Executive Kym Denny.

The company said, however, that the GBP10.0 million revenue from the programme will not be fully-recognised until the end of its financial year to December 2016.

"In making the transition from service provider to vested owner, it is unfortunate that the accounting technicalities are such that we may not be able to recognise revenue in 2015 for the great work being conducted on this product in 2015. Ultimately this has no net effect, including to cash flow, other than the timing difference of revenue moving out of 2015 and into 2016," Denny added.

Shares in hVIVO were down 2.1% to 260.00 pence on Monday.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2023 14:39

EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
3 Apr 2023 12:13

hVIVO touts positive test results from seasonal flu drug, CD388

(Alliance News) - hVIVO PLC on Monday said that Cidara Therapeutics Inc has seen positive results from an ongoing study testing CD388, a drug designed to treat seasonal flu.

Read more
16 Mar 2023 17:32

TRADING UPDATES: Inspirit Energy reports progress on Inspirit Charger

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 Mar 2023 17:31

TRADING UPDATES: Inspirit Energy reports progress on Inspirit Charger

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 Mar 2023 15:48

hVIVO manufactures human challenge agent for Omicron

(Sharecast News) - Specialist contract research organisation hVIVO has successfully manufactured its Omicron human challenge agent, it announced on Thursday.

Read more
6 Feb 2023 11:00

hVIVO signs GBP6.8 million deal to test RSV antiviral drug candidate

(Alliance News) - hVIVO PLC on Monday said it has signed a GBP6.8 million contract with a leading Asia-Pacific pharmaceutical company, to test its respiratory synctical virus antiviral drug candidate.

Read more
25 Jan 2023 12:38

hVIVO expecting record year; 2023 orderbook soars by 65% against 2022

(Alliance News) - hVIVO PLC on Wednesday said it expects to report record revenue for 2022, as it reported a strong order book.

Read more
18 Jan 2023 15:50

UK earnings, trading statements calendar - next 7 days

Thursday 19 January 
AJ Bell PLCTrading Statement
Bakkavor Group PLCTrading Statement
BHP Group LtdTrading Statement
boohoo Group PLCTrading Statement
Centamin PLCTrading Statement
Deliveroo PLCTrading Statement
Dunelm Group PLCTrading Statement
Energean PLCTrading Statement
Frontier Developments PLCHalf Year Results
Harbour Energy PLCTrading Statement
Headlam Group PLCTrading Statement
Ilika PLCHalf Year Results
Kier Group PLCTrading Statement
Luceco PLCTrading Statement
Network International Holdings PLCTrading Statement
Premier Foods PLCTrading Statement
Sage Group PLCTrading Statement
Zotefoams PLCTrading Statement
Friday 20 January 
4imprint Group PLCTrading Statement
Close Brothers Group PLCTrading Statement
Goldplat PLCFull Year Results
Ninety One PLCTrading Statement
Workspace Group PLCTrading Statement
PensionBee Group PLCTrading Statement
TheWorks.co.uk PLCHalf Year Results
Monday 23 January 
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Tuesday 24 January 
Accrol Group Holdings PLCHalf Year Results
Associated British Foods PLCTrading Statement
Henry Boot PLCTrading Statement
Oxford BioDynamics PLCFull Year Results
Saga PLCTrading Statement
Staffline Group PLCTrading Statement
Sureserve Group PLCFull Year Results
Velocity Composites PLCFull Year Results
Wednesday 25 January 
CMC Markets PLCTrading Statement
Conduit Holdings LtdTrading Statement
easyJet PLCTrading Statement
Forterra PLCTrading Statement
Hargreaves Services PLCHalf Year Results
hVIVO PLCTrading Statement
JD Wetherspoon PLCTrading Statement
Keywords Studios PLCTrading Statement
Quilter PLCTrading Statement
Scancell Holdings PLCHalf Year Results
Tullow Oil PLCTrading Statement
Van Elle Holdings PLCHalf Year Results
Watkin Jones PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
17 Jan 2023 16:23

TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
4 Jan 2023 10:40

hVIVO signs contract in Asia Pacific to test RSV vaccine candidate

(Alliance News) - hVIVO PLC on Wednesday said it signed a GBP5.2 million contract with a "global biotechnology company" headquartered in Asia Pacific in order to test their respiratory syncytial virus vaccine candidate.

Read more
4 Jan 2023 07:50

hVIVO inks £5.2m contract with biotechnology group

(Sharecast News) - Contract research organisation hVIVO has signed a £5.2m contract with a global biotechnology company to test its respiratory syncytial virus vaccine candidate.

Read more
19 Dec 2022 18:20

TRADING UPDATES: Gulf Keystone chair to retire; JZ Capital cashes in

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
10 Nov 2022 21:19

TRADING UPDATES: Zambeef expects profit jump; Mobile Streams wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Oct 2022 14:53

TRADING UPDATES: Gunsynd invests; AQRU launches crypto-backed loans

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
17 Jan 2020 10:51

Open Orphan Takeover Of hVIVO Now Wholly Unconditional

Open Orphan Takeover Of hVIVO Now Wholly Unconditional

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.